PRINZI, NATALIE
 Distribuzione geografica
Continente #
NA - Nord America 1.143
EU - Europa 414
AS - Asia 192
AF - Africa 11
SA - Sud America 9
OC - Oceania 1
Totale 1.770
Nazione #
US - Stati Uniti d'America 1.140
IT - Italia 206
SE - Svezia 66
SG - Singapore 63
CN - Cina 57
DE - Germania 53
IN - India 45
FI - Finlandia 25
GB - Regno Unito 14
HK - Hong Kong 11
TG - Togo 10
FR - Francia 8
UA - Ucraina 8
AR - Argentina 7
ID - Indonesia 7
RO - Romania 7
BG - Bulgaria 6
NL - Olanda 6
RU - Federazione Russa 5
IE - Irlanda 4
MY - Malesia 4
AL - Albania 2
CA - Canada 2
ES - Italia 2
PT - Portogallo 2
AU - Australia 1
CL - Cile 1
IR - Iran 1
KZ - Kazakistan 1
LK - Sri Lanka 1
PA - Panama 1
PY - Paraguay 1
TR - Turchia 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 1.770
Città #
Fairfield 175
Ashburn 131
Chandler 128
Woodbridge 79
Seattle 78
Wilmington 68
Cambridge 60
Rome 60
Houston 58
Singapore 46
Beijing 29
Princeton 28
Ann Arbor 22
Plano 22
Lawrence 20
San Paolo di Civitate 20
Dearborn 18
Millbury 17
Santa Clara 16
Milan 13
San Diego 12
Washington 12
Central 11
Lomé 10
Boston 9
Florence 9
New York 9
Feltham 8
Turin 8
Federal 7
Jakarta 7
Andover 6
Bühl 6
Des Moines 6
Naples 6
Sofia 6
Helsinki 5
Nanjing 5
Redwood City 5
Amsterdam 4
Bologna 4
Dublin 4
Norwalk 4
Padova 4
Bremen 3
Buffalo 3
Kunming 3
London 3
Los Angeles 3
Mannheim 3
Phoenix 3
Springfield 3
Busto Arsizio 2
Falkenstein 2
Falls Church 2
Fremont 2
Giugliano in Campania 2
Guangzhou 2
Hefei 2
Lafayette 2
Manfredonia 2
Munich 2
Nanchang 2
Palermo 2
Palo del Colle 2
Pavia 2
Portici 2
Racale 2
San Mateo 2
Siena 2
Simi Valley 2
Toronto 2
Trecastelli 2
Almaty 1
Asunción 1
Baotou 1
Bellusco 1
Bergamo 1
Biella 1
Castel Volturno 1
Catania 1
Chicago 1
Colombo 1
Copertino 1
Corchiano 1
Dallas 1
Delhi 1
Dreieich 1
Fiuggi 1
Formia 1
Grafing 1
Istanbul 1
Jacksonville 1
Jinan 1
Lappeenranta 1
Lisbon 1
Livorno 1
Martellago 1
Modderfontein 1
Mumbai 1
Totale 1.348
Nome #
Alterata espressione dei geni coinvolti nel processo di sumoilazione nel carcinoma papillare della tiroide. 151
Association of thyroid diseases with primary extra-thyroidal malignancies in women. Results of a cross-sectional study of 6,386 patients 126
Grey-scale analysis improves the ultrasonographic evaluation of thyroid nodules 102
Thyroid autoantibodies and breast cancer 101
Deregulated expression of Aurora kinases is not a prognostic biomarker in papillary thyroid cancer patients 98
New molecular approaches in the diagnosis and prognosis of thyroid cancer patients 91
Preclinical testing of selective Aurora kinase inhibitors on a medullary thyroid carcinoma-derived cell line 83
Consumption of iodized salt may not represent a reliable indicator of iodine adequacy. Evidence from a cross-sectional study on schoolchildren living in an urban area of central Italy 80
Prevalence of breast cancer in thyroid diseases. Results of a cross-sectional study of 3,921 patients 78
Emerging molecular markers for the prognosis of differentiated thyroid cancer patients 74
Rationale and protocol of MetNET-2 trial: Lanreotide Autogel plus metformin in advanced gastrointestinal or lung neuroendocrine tumors 73
Selective inhibitors of aurora kinases inhibit proliferation, reduce cell viability and impair cell cycle progression in papillary thyroid carcinoma cells 73
Subcutaneous metastases from colon cancer: A case report 71
Correlation between fertility drugs use and malignant melanoma incidence: the state of the art 71
Fertility drugs, reproductive strategies and ovarian cancer risk 68
Update on medical treatment of small intestinal neuroendocrine tumors 64
Primary cerebellar neuroendocrine tumors: chimeras or real entities? A case report with a 6-year follow-up 64
Effects of selective inhibitors of Aurora kinases on anaplastic thyroid carcinoma cell lines 63
Nutritional status and follicular-derived thyroid cancer. An update 61
Peptide receptor radionuclide therapy: focus on bronchial neuroendocrine tumors 58
Ability of selective small molecule inhibitors of Aurora-A and Aurora-B in inhibiting tumorigenicity of anaplastic thyroid carcinoma-derived cell lines. 50
Expected and paradoxical effects of obesity on cancer treatment response 50
The dual Aurora kinase inhibitor ZM447439 prevents anaplastic thyroid cancer cell growth and tumorigenicity 48
Surgical strategies in patients with medullary thyroid carcinoma 41
Gender-related differences in patients with carcinoid syndrome: new insights from an Italian multicenter cohort study 21
Totale 1.860
Categoria #
all - tutte 5.184
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.184


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020310 0 0 0 0 34 47 64 50 50 34 19 12
2020/2021144 14 19 7 2 19 18 14 6 11 20 10 4
2021/2022281 10 11 23 20 33 13 6 20 26 21 44 54
2022/2023361 52 94 23 34 32 40 6 25 30 4 15 6
2023/2024255 14 22 19 7 24 75 15 9 5 38 16 11
2024/2025110 28 10 18 17 37 0 0 0 0 0 0 0
Totale 1.860